SynBiotic SE

XETRA SBX.DE

SynBiotic SE Goodwill for the year ending December 31, 2023: USD 23.11 M

SynBiotic SE Goodwill is USD 23.11 M for the year ending December 31, 2023, a -11.46% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • SynBiotic SE Goodwill for the year ending December 31, 2022 was USD 26.10 M, a -41.66% change year over year.
  • SynBiotic SE Goodwill for the year ending December 31, 2021 was USD 44.73 M, a 51.06% change year over year.
  • SynBiotic SE Goodwill for the year ending December 31, 2020 was USD 29.61 M.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
XETRA: SBX.DE

SynBiotic SE

CEO Mr. Daniel Kruse
IPO Date Jan. 7, 2021
Location Germany
Headquarters Innere Wiener Str. 14
Employees 55
Sector Health Care
Industries
Pharmaceuticals Biotechnology Cosmetics
Description

SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.

StockViz Staff

January 16, 2025

Any question? Send us an email